Blood Eosinophils and outcomes in severe hospitalized exacerbations of COPD

Blood Eosinophils and outcomes in severe hospitalized exacerbations of COPD

Background Patients with moderate exacerbations of COPD and the eosinophilic phenotype have better outcomes with prednisolone. Whether this outcome is similar in patients hospitalized with a severe exacerbation of COPD is unclear. We investigated the rate of recovery of eosinophilic and noneosinophi...

Detaylı Bibliyografya
Asıl Yazarlar:	Bafadhel, M, Greening, NJ, Harvey-Dunstan, TC, Williams, JE, Morgan, MD, Brightling, CE, Hussain, SF, Pavord, ID, Singh, SJ, Steiner, MC
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	Elsevier 2016

Benzer Materyaller

Blood eosinophil guided prednisolone therapy for exacerbations of COPD: a further analysis.
Yazar:: Bafadhel, M, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Inhaled glucocorticoids and COPD exacerbations.
Yazar:: Brightling, C, ve diğerleri
Baskı/Yayın Bilgisi: (2015)

Characterisation of exacerbations of severe eosinophilic asthma (SEA) on mepolizumab compared to placebo
Yazar:: Shrimanker, R, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

COPD exacerbation severity and frequency is associated with impaired macrophage efferocytosis of eosinophils
Yazar:: Eltboli, O, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Seasonality of eosinophilic and non-eosinophilic exacerbations of COPD
Yazar:: Barker, R, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Characterising non-eosinophilic COPD
Yazar:: Hambleton, K, ve diğerleri
Baskı/Yayın Bilgisi: (2015)

Blood eosinophils: a biomarker of COPD exacerbation reduction with inhaled corticosteroids
Yazar:: Siddiqui SH, ve diğerleri
Baskı/Yayın Bilgisi: (2018-11-01)

Eosinophils in COPD: just another biomarker?
Yazar:: Bafadhel, M, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Effect of levofloxacin on neutrophilic airway inflammation in stable COPD: a randomized, double-blind, placebo-controlled trial
Yazar:: Siva R, ve diğerleri
Baskı/Yayın Bilgisi: (2014-02-01)

Airway bacteria measured by quantitative polymerase chain reaction and culture in patients with stable COPD: relationship with neutrophilic airway inflammation, exacerbation frequency, and lung function
Yazar:: Bafadhel M, ve diğerleri
Baskı/Yayın Bilgisi: (2015-06-01)

Blood eosinophil count and exacerbation risk in patients with COPD.
Yazar:: Kerkhof, M, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial.
Yazar:: Siva, R, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Exacerbations of COPD
Yazar:: Pavord ID, ve diğerleri
Baskı/Yayın Bilgisi: (2016-02-01)

Blood eosinophil count and GOLD stage predict response to maintenance azithromycin treatment in COPD patients with frequent exacerbations
Yazar:: Djamin, R, ve diğerleri
Baskı/Yayın Bilgisi: (2019)

The acute wheezy adult with airways disease in the emergency department: a retrospective case-note review of exacerbations of COPD
Yazar:: Russell REK, ve diğerleri
Baskı/Yayın Bilgisi: (2019-05-01)

Blood eosinophils: a biomarker of COPD exacerbation reduction with inhaled corticosteroids
Yazar:: Siddiqui, S, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease (COPD): A Meta-Analysis of METREX and METREO Exacerbation Endpoints
Yazar:: Bafadhel, M, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Shall we focus on the eosinophil to guide treatment with systemic corticosteroids during acute exacerbations of COPD?: PRO
Yazar:: Camp, J, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Lung microbiome dynamics in COPD exacerbations
Yazar:: Wang, Z, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Shall We Focus on the Eosinophil to Guide Treatment with Systemic Corticosteroids during Acute Exacerbations of COPD?: PRO
Yazar:: James Camp, ve diğerleri
Baskı/Yayın Bilgisi: (2018-09-01)

Aspergillus fumigatus during stable state and exacerbations of COPD.
Yazar:: Bafadhel, M, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

The peripheral blood eosinophil count as a biomarker of eosinophilic airway inflammation in patients with asthma and COPD. Experience from a single centre
Yazar:: Shrimanker, R, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Association between blood eosinophil count and risk of exacerbations in patients with COPD
Yazar:: Kerkhof, M, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

COPD in the time of COVID-19: an analysis of acute exacerbations and reported behavioural changes in patients with COPD
Yazar:: Hamish McAuley, ve diğerleri
Baskı/Yayın Bilgisi: (2021-01-01)

Association Between Pathogens Detected Using Quantitative Polymerase Chain Reaction With Airway Inflammation in COPD at Stable State and Exacerbations.
Yazar:: Barker, B, ve diğerleri
Baskı/Yayın Bilgisi: (2015)

Mepolizumab and exacerbations of refractory eosinophilic asthma.
Yazar:: Haldar, P, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Copd in the ed: eosinophils, treatment and outcomes, data from the pre-award study
Yazar:: Russell, R, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Mepolizumab for eosinophilic COPD
Yazar:: Sciurba, F, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Clinical characterisation of exacerbations of severe eosinophilic asthma occurring on mepolizumab and placebo
Yazar:: Howell, I, ve diğerleri
Baskı/Yayın Bilgisi: (2024)

Stability in eosinophil categorisation during subsequent severe exacerbations of COPD
Yazar:: Huib A M Kerstjens, ve diğerleri
Baskı/Yayın Bilgisi: (2021-01-01)

Evaluation of exacerbations and blood eosinophils in UK and US COPD populations
Yazar:: Claus F. Vogelmeier, ve diğerleri
Baskı/Yayın Bilgisi: (2019-08-01)

COPD exacerbations: transforming outcomes through research
Yazar:: Hurst, JR, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial.
Yazar:: Bafadhel, M, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Investigating blood eosinophil count thresholds in patients with COPD
Yazar:: Russell, R, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

The significance of eosinophilic inflammation in COPD
Yazar:: Cooper, C, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Variability of blood eosinophil count and prognosis of COPD exacerbations
Yazar:: Sandra Martínez-Gestoso, ve diğerleri
Baskı/Yayın Bilgisi: (2021-01-01)

Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial.
Yazar:: Green, R, ve diğerleri
Baskı/Yayın Bilgisi: (2002)

Eosinophils in asthma and airway hyperresponsiveness.
Yazar:: Brightling, C, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Building toolkits for COPD exacerbations: lessons from the past and present
Yazar:: Sapey, E, ve diğerleri
Baskı/Yayın Bilgisi: (2019)

Is it time to give up on "self-management" of COPD exacerbations?
Yazar:: Ramakrishnan, S, ve diğerleri
Baskı/Yayın Bilgisi: (2020)